FDA.reportPublic FDA data

Revalor-XS (trenbolone acetate 200 MG / estradiol 40 MG) Drug Implant

RxCUI
1668218
RxNorm name
Revalor-XS (trenbolone acetate 200 MG / estradiol 40 MG) Drug Implant
Display name
Revalor-XS (trenbolone acetate 200 MG / estradiol 40 MG) Drug Implant
Full name
Revalor-XS (trenbolone acetate 200 MG / estradiol 40 MG) Drug Implant
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2741349c-8a48-4d09-b74c-d92d35f0593dRevalor-XS (trenbolone acetate 200 MG / estradiol 40 MG) Drug Implant [PSN] · estradiol 40 MG / trenbolone acetate 200 MG Drug Implant [Revalor] [SBD] · Revalor-XS (trenbolone acetate 200 MG / estradiol 40 MG) Drug Implant [SY]38Revalor ® -XS (trenbolone acetate and estradiol extended-release implants)20250815